Ra Capital Management as of June 30, 2016
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 32 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences (WVE) | 20.3 | $147M | 7.1M | 20.69 | |
| Achillion Pharmaceuticals | 13.0 | $94M | 12M | 7.80 | |
| Axovant Sciences | 8.9 | $64M | 5.0M | 12.84 | |
| Avexis | 7.0 | $51M | 1.3M | 38.02 | |
| Aclaris Therapeutics (ACRS) | 6.7 | $49M | 2.6M | 18.47 | |
| Nektar Therapeutics (NKTR) | 6.3 | $46M | 3.2M | 14.23 | |
| Ascendis Pharma A S (ASND) | 6.3 | $45M | 3.4M | 13.27 | |
| Tg Therapeutics (TGTX) | 3.8 | $28M | 4.5M | 6.06 | |
| Ardelyx (ARDX) | 2.8 | $20M | 2.3M | 8.73 | |
| Zogenix | 2.7 | $20M | 2.5M | 8.05 | |
| Vitae Pharmaceuticals | 2.4 | $17M | 1.6M | 10.79 | |
| Aimmune Therapeutics | 1.9 | $14M | 1.3M | 10.82 | |
| Alcobra | 1.9 | $14M | 3.0M | 4.49 | |
| Proteon Therapeutics | 1.8 | $13M | 1.6M | 8.03 | |
| Aquinox Pharmaceuticals | 1.6 | $11M | 1.7M | 6.62 | |
| Strongbridge Bioph shs usd | 1.5 | $11M | 2.7M | 3.98 | |
| Natera (NTRA) | 1.3 | $9.4M | 784k | 12.06 | |
| Dimension Therapeutics | 1.3 | $9.3M | 1.5M | 6.00 | |
| BioCryst Pharmaceuticals (BCRX) | 1.2 | $8.5M | 3.0M | 2.84 | |
| Dicerna Pharmaceuticals | 1.0 | $7.3M | 2.4M | 3.00 | |
| Sangamo Biosciences (SGMO) | 0.9 | $6.8M | 1.2M | 5.79 | |
| Agile Therapeutics | 0.9 | $6.5M | 853k | 7.61 | |
| Tenax Therapeutics | 0.8 | $6.1M | 2.4M | 2.56 | |
| Eiger Biopharmaceuticals | 0.8 | $5.8M | 292k | 19.82 | |
| Beigene (BGNE) | 0.7 | $5.1M | 170k | 29.80 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.6 | $4.2M | 411k | 10.31 | |
| Akari Therapeutics | 0.4 | $3.2M | 234k | 13.49 | |
| Aeglea Biotherapeutics | 0.3 | $2.5M | 522k | 4.86 | |
| Merus N V (MRUS) | 0.3 | $1.9M | 238k | 7.99 | |
| Zynerba Pharmaceuticals | 0.2 | $1.7M | 254k | 6.85 | |
| Arca Biopharma | 0.2 | $1.6M | 563k | 2.90 | |
| Pronai Therapeutics | 0.0 | $59k | 30k | 1.99 |
